To test for an association between season and amyloid and tau biology, we analyzed CSF amyloid and tau levels in patients with (n = 176) and without (n = 145) clinical AD from the CNC cohort, an observational cohort study of patients from a tertiary care memory center in Paris, France (Table 1; n = 321). This evidence concerns the gene MAPT and Alzheimer disease.